Registry organizations: Efficacy Evaluation of Glimepiride in Patients With Type 2 Diabetes Mellitus and Chronic Heart Failure With Reduced Ejection Fraction.
13 registry organizations linked to Efficacy Evaluation of Glimepiride in Patients With Type 2 Diabetes Mellitus and Chronic Heart Failure With Reduced Ejection Fraction., by name. Assembled by a program from ROR and ClinicalTrials.gov. No person wrote or checked these pages, and they are counted apart from the pages that people wrote. Lists of trials come from the registry's own coding and may miss trials.
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 3 trials in this atlas.
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 53 trials in this atlas.
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 32 trials in this atlas.
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 9 trials in this atlas.
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 8 trials in this atlas.
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 7 trials in this atlas.
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 13 trials in this atlas.
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 31 trials in this atlas.
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 3 trials in this atlas.
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 25 trials in this atlas.
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 18 trials in this atlas.
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 10 trials in this atlas.
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 5 trials in this atlas.